Table of Contents
ISRN Pharmacology
Volume 2011 (2011), Article ID 430549, 8 pages
http://dx.doi.org/10.5402/2011/430549
Research Article

Carvedilol-Afforded Protection against Daunorubicin-Induced Cardiomyopathic Rats In Vivo: Effects on Cardiac Fibrosis and Hypertrophy

1Department of Clinical Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, 265-1 Higashijima Akiha-Ku, Niigata City 956-8603, Japan
2Department of Pharmacology, Faculty of Medicine, University of Indonesia, Jakarta 10430, Indonesia
3Department of Pharmacology, Faculty of Medicine and Health Sciences, Syarif Hidayatullah Jakarta, State Islamic University, South Jakarta 15412, Indonesia
4Department of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8510, Japan

Received 31 January 2011; Accepted 10 March 2011

Academic Editors: M. Brunner and D. K. Miller

Copyright © 2011 Wawaimuli Arozal et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Wawaimuli Arozal, Flori R. Sari, Kenichi Watanabe, et al., “Carvedilol-Afforded Protection against Daunorubicin-Induced Cardiomyopathic Rats In Vivo: Effects on Cardiac Fibrosis and Hypertrophy,” ISRN Pharmacology, vol. 2011, Article ID 430549, 8 pages, 2011. doi:10.5402/2011/430549